Literature DB >> 18274717

[Classification, genetic predisposition and risk factors for the development of cardiomyopathies].

S Pankuweit1, A Richter, V Ruppert, R Funck, B Maisch.   

Abstract

Cardiomyopathies are an important and diverse group of heart muscle diseases in which the heart muscle itself is structural or functional abnormal. This often results in severe heart failure accompanied by arrhythmias and/or sudden death. Clinical and morphological diversity of cardiomyopathies can reflect the broad spectrum of distinct underlying molecular causes or genetic heterogeneity. In addition, modifying genes, life style and additional factors were reported to influence onset of disease, disease progression and prognosis. The individual patient's phenotype may reflect a summation and/or interaction of the underlying mutation with other genetic or environmental factors. During the last years major advances have been made in the understanding of the molecular and genetic basis of this type of disease. Nevertheless, much more progress in the identification of underlying mutations, susceptibility genes and modifier genes is important and indispensable for the development of new etiology orientated forms of therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18274717     DOI: 10.1007/s00108-008-2050-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

Review 1.  Restrictive cardiomyopathy.

Authors:  S S Kushwaha; J T Fallon; V Fuster
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

Review 2.  Inflammatory dilated cardiomyopathy (DCMI).

Authors:  Bernhard Maisch; Anette Richter; Andrea Sandmöller; Irene Portig; Sabine Pankuweit
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

Review 4.  Clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Emily L Burkett; Ray E Hershberger
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

Review 5.  Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.

Authors:  W Poller; U Kühl; C Tschoepe; M Pauschinger; H Fechner; H-P Schultheiss
Journal:  J Mol Med (Berl)       Date:  2005-06-02       Impact factor: 4.599

6.  Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.

Authors:  Daniela Massi; Alessandro Franchi; Sheyda Ketabchi; Milena Paglierani; Nicola Pimpinelli; Marco Santucci
Journal:  Hum Pathol       Date:  2003-01       Impact factor: 3.466

7.  Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity.

Authors:  Shiwei Deng; Bettina Kulle; Mehdi Hosseini; Gregor Schlüter; Gerd Hasenfuss; Leszek Wojnowski; Albrecht Schmidt
Journal:  Eur J Heart Fail       Date:  2007-09-20       Impact factor: 15.534

8.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

9.  Epidemiology of idiopathic dilated cardiomyopathy in the elderly: pooled results from two case-control studies.

Authors:  S S Coughlin; M C Tefft; J C Rice; J L Gerone; K L Baughman
Journal:  Am J Epidemiol       Date:  1996-05-01       Impact factor: 4.897

Review 10.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation.

Authors:  D Corrado; G Fontaine; F I Marcus; W J McKenna; A Nava; G Thiene; T Wichter
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

View more
  2 in total

1.  [Cardiac magnetic resonance tomography in the diagnostics of restrictive and unclassified cardiopathies].

Authors:  U Kramer; A E May; S Mangold; P Krumm; C D Claussen
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

Review 2.  A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review.

Authors:  Karsten Keller; Johannes Beule; Jörn Oliver Balzer; Meike Coldewey; Thomas Munzel; Wolfgang Dippold; Philipp Wild
Journal:  Wien Klin Wochenschr       Date:  2013-12-17       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.